Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lipoprotein(a) | 25 | 2024 | 490 | 7.320 |
Why?
|
Coronary Artery Disease | 55 | 2025 | 6566 | 6.830 |
Why?
|
Cardiovascular Diseases | 61 | 2025 | 15652 | 4.340 |
Why?
|
Genome-Wide Association Study | 83 | 2025 | 12775 | 3.430 |
Why?
|
Menopause, Premature | 6 | 2023 | 124 | 3.420 |
Why?
|
Multifactorial Inheritance | 22 | 2024 | 1421 | 3.110 |
Why?
|
Mendelian Randomization Analysis | 22 | 2025 | 1037 | 2.910 |
Why?
|
Atherosclerosis | 27 | 2024 | 3431 | 2.820 |
Why?
|
Hematopoiesis | 26 | 2024 | 2058 | 2.740 |
Why?
|
Dioxygenases | 11 | 2024 | 351 | 2.170 |
Why?
|
Hypertension | 13 | 2024 | 8615 | 1.950 |
Why?
|
Genetic Predisposition to Disease | 61 | 2025 | 18047 | 1.940 |
Why?
|
Primary Prevention | 7 | 2022 | 1187 | 1.820 |
Why?
|
Lipids | 16 | 2024 | 3344 | 1.800 |
Why?
|
Risk Factors | 109 | 2025 | 74954 | 1.780 |
Why?
|
Phospholipids | 5 | 2024 | 783 | 1.730 |
Why?
|
Receptors, Interleukin-6 | 5 | 2023 | 224 | 1.710 |
Why?
|
Cholesterol, LDL | 29 | 2024 | 2398 | 1.690 |
Why?
|
Hematopoietic Stem Cells | 17 | 2024 | 3407 | 1.530 |
Why?
|
Hyperlipoproteinemia Type II | 10 | 2025 | 407 | 1.490 |
Why?
|
Polymorphism, Single Nucleotide | 45 | 2025 | 16027 | 1.440 |
Why?
|
Oxidation-Reduction | 4 | 2024 | 2225 | 1.360 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2024 | 3252 | 1.300 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2024 | 523 | 1.290 |
Why?
|
Vascular Diseases | 5 | 2024 | 1161 | 1.270 |
Why?
|
Humans | 286 | 2025 | 768298 | 1.230 |
Why?
|
Apolipoprotein B-100 | 5 | 2024 | 157 | 1.220 |
Why?
|
Genetic Variation | 17 | 2024 | 6606 | 1.220 |
Why?
|
Triglycerides | 14 | 2024 | 2465 | 1.200 |
Why?
|
Coronary Disease | 16 | 2023 | 5926 | 1.190 |
Why?
|
Pre-Eclampsia | 5 | 2024 | 1255 | 1.140 |
Why?
|
Venous Thromboembolism | 8 | 2024 | 1881 | 1.140 |
Why?
|
Biological Specimen Banks | 14 | 2024 | 782 | 1.120 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1885 | 1.100 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 518 | 1.050 |
Why?
|
Cholesterol Ester Transfer Proteins | 4 | 2023 | 113 | 1.030 |
Why?
|
Mutation | 38 | 2024 | 30230 | 1.030 |
Why?
|
Pneumonia | 3 | 2022 | 2162 | 0.990 |
Why?
|
Middle Aged | 103 | 2025 | 223463 | 0.960 |
Why?
|
Blood Pressure | 13 | 2024 | 8541 | 0.950 |
Why?
|
Dyslipidemias | 4 | 2024 | 873 | 0.940 |
Why?
|
Manipulation, Osteopathic | 1 | 2024 | 3 | 0.930 |
Why?
|
Female | 143 | 2025 | 397050 | 0.910 |
Why?
|
Heart Failure | 14 | 2024 | 11860 | 0.900 |
Why?
|
Genome, Human | 8 | 2021 | 4450 | 0.880 |
Why?
|
Coronary Vessel Anomalies | 2 | 2024 | 308 | 0.880 |
Why?
|
Coronary Angiography | 8 | 2025 | 4537 | 0.840 |
Why?
|
Chromosomes, Human, X | 2 | 2024 | 320 | 0.840 |
Why?
|
Risk Assessment | 23 | 2025 | 24316 | 0.840 |
Why?
|
Eclampsia | 1 | 2023 | 60 | 0.820 |
Why?
|
Apolipoprotein C-III | 4 | 2024 | 210 | 0.820 |
Why?
|
Male | 127 | 2025 | 364870 | 0.810 |
Why?
|
Photoplethysmography | 2 | 2020 | 66 | 0.810 |
Why?
|
Hypercholesterolemia | 8 | 2024 | 1142 | 0.810 |
Why?
|
Atrial Fibrillation | 10 | 2024 | 5168 | 0.790 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 181 | 0.770 |
Why?
|
Aging | 8 | 2024 | 8764 | 0.770 |
Why?
|
Life Style | 7 | 2024 | 3930 | 0.750 |
Why?
|
Hepatitis | 1 | 2023 | 227 | 0.740 |
Why?
|
Aged | 69 | 2025 | 171544 | 0.740 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2024 | 12239 | 0.720 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1597 | 0.720 |
Why?
|
Myocardial Infarction | 15 | 2024 | 11515 | 0.710 |
Why?
|
Peripheral Arterial Disease | 5 | 2024 | 1303 | 0.710 |
Why?
|
Parasympathetic Nervous System | 1 | 2020 | 144 | 0.690 |
Why?
|
Secondary Prevention | 3 | 2024 | 1476 | 0.670 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2023 | 709 | 0.670 |
Why?
|
Cholesterol, HDL | 9 | 2024 | 1820 | 0.660 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.650 |
Why?
|
Disease Susceptibility | 2 | 2023 | 1795 | 0.640 |
Why?
|
Aortic Valve Stenosis | 7 | 2024 | 2034 | 0.640 |
Why?
|
Adult | 75 | 2024 | 223622 | 0.640 |
Why?
|
Menopause | 4 | 2023 | 1653 | 0.620 |
Why?
|
Genomics | 12 | 2025 | 5916 | 0.620 |
Why?
|
Genetics, Population | 3 | 2024 | 942 | 0.620 |
Why?
|
Metabolomics | 3 | 2024 | 1675 | 0.610 |
Why?
|
Incidence | 16 | 2024 | 21544 | 0.610 |
Why?
|
Proteomics | 4 | 2024 | 3906 | 0.610 |
Why?
|
DNA-Binding Proteins | 13 | 2024 | 9618 | 0.610 |
Why?
|
Postmenopause | 4 | 2023 | 2518 | 0.610 |
Why?
|
Microvessels | 2 | 2024 | 586 | 0.610 |
Why?
|
Phenotype | 28 | 2025 | 16716 | 0.600 |
Why?
|
Microcirculation | 2 | 2024 | 1282 | 0.590 |
Why?
|
Sympathetic Nervous System | 1 | 2020 | 521 | 0.590 |
Why?
|
Proto-Oncogene Proteins | 8 | 2024 | 4526 | 0.590 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.570 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 357 | 0.570 |
Why?
|
Electronic Health Records | 5 | 2024 | 4874 | 0.570 |
Why?
|
Ventricular Remodeling | 3 | 2024 | 1281 | 0.560 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.550 |
Why?
|
Apolipoproteins | 1 | 2019 | 328 | 0.550 |
Why?
|
Carotid Stenosis | 1 | 2024 | 862 | 0.540 |
Why?
|
C-Reactive Protein | 4 | 2024 | 3859 | 0.540 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2295 | 0.530 |
Why?
|
Apolipoprotein A-I | 4 | 2023 | 305 | 0.520 |
Why?
|
Fingers | 1 | 2019 | 512 | 0.520 |
Why?
|
Veterans | 10 | 2024 | 2672 | 0.520 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1548 | 0.510 |
Why?
|
Janus Kinase 2 | 3 | 2024 | 561 | 0.500 |
Why?
|
RNA, Small Interfering | 2 | 2024 | 3436 | 0.500 |
Why?
|
Risk Reduction Behavior | 1 | 2022 | 1119 | 0.490 |
Why?
|
Prospective Studies | 24 | 2024 | 54921 | 0.490 |
Why?
|
Lipid Metabolism | 5 | 2021 | 1900 | 0.490 |
Why?
|
Cohort Studies | 24 | 2024 | 41791 | 0.490 |
Why?
|
Models, Genetic | 5 | 2024 | 3442 | 0.490 |
Why?
|
Lipoproteins, HDL | 4 | 2023 | 682 | 0.480 |
Why?
|
Penetrance | 1 | 2016 | 384 | 0.480 |
Why?
|
Interleukin-6 | 3 | 2024 | 3230 | 0.450 |
Why?
|
Sex Characteristics | 4 | 2024 | 2661 | 0.450 |
Why?
|
Disease Progression | 5 | 2024 | 13646 | 0.450 |
Why?
|
Hematologic Neoplasms | 5 | 2024 | 1906 | 0.450 |
Why?
|
Cardiovascular System | 1 | 2021 | 838 | 0.450 |
Why?
|
Proteome | 5 | 2024 | 1880 | 0.440 |
Why?
|
Disease Management | 3 | 2022 | 2536 | 0.440 |
Why?
|
Genetic Association Studies | 9 | 2022 | 2741 | 0.440 |
Why?
|
Anticholesteremic Agents | 2 | 2022 | 972 | 0.430 |
Why?
|
Coronary Stenosis | 1 | 2019 | 802 | 0.420 |
Why?
|
Health Status | 4 | 2023 | 4094 | 0.420 |
Why?
|
Asymptomatic Diseases | 3 | 2024 | 590 | 0.420 |
Why?
|
Clone Cells | 3 | 2024 | 1671 | 0.410 |
Why?
|
Communicable Diseases | 1 | 2021 | 873 | 0.410 |
Why?
|
Inflammation | 6 | 2024 | 10863 | 0.410 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1957 | 0.410 |
Why?
|
Stroke | 7 | 2024 | 9742 | 0.400 |
Why?
|
Coronary Vessels | 3 | 2024 | 3125 | 0.400 |
Why?
|
Genotype | 16 | 2024 | 13038 | 0.390 |
Why?
|
Chromosome Aberrations | 4 | 2022 | 1780 | 0.390 |
Why?
|
Lipoproteins | 4 | 2021 | 880 | 0.390 |
Why?
|
Retina | 2 | 2024 | 2661 | 0.380 |
Why?
|
Hypolipidemic Agents | 3 | 2021 | 609 | 0.370 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1943 | 0.370 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2021 | 325 | 0.370 |
Why?
|
Quantitative Trait Loci | 7 | 2024 | 2127 | 0.360 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 878 | 0.350 |
Why?
|
Inflammasomes | 3 | 2024 | 540 | 0.340 |
Why?
|
Gene Frequency | 6 | 2021 | 3615 | 0.340 |
Why?
|
Stroke Volume | 5 | 2024 | 5620 | 0.340 |
Why?
|
Receptors, LDL | 7 | 2024 | 491 | 0.330 |
Why?
|
Women's Health | 5 | 2024 | 2078 | 0.330 |
Why?
|
Mosaicism | 2 | 2024 | 481 | 0.330 |
Why?
|
Repressor Proteins | 5 | 2024 | 2986 | 0.320 |
Why?
|
DNA Damage | 1 | 2019 | 2459 | 0.320 |
Why?
|
Heart Ventricles | 2 | 2022 | 3838 | 0.320 |
Why?
|
Heart Rate | 1 | 2020 | 4218 | 0.320 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15455 | 0.320 |
Why?
|
HIV Infections | 3 | 2024 | 17575 | 0.310 |
Why?
|
Cause of Death | 1 | 2019 | 3728 | 0.310 |
Why?
|
Apolipoproteins B | 4 | 2023 | 386 | 0.300 |
Why?
|
Mass Screening | 2 | 2021 | 5451 | 0.300 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12557 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3440 | 0.290 |
Why?
|
Medical History Taking | 2 | 2022 | 776 | 0.290 |
Why?
|
Odds Ratio | 7 | 2023 | 9681 | 0.280 |
Why?
|
Animals | 33 | 2024 | 169322 | 0.280 |
Why?
|
Sepsis | 1 | 2021 | 2601 | 0.280 |
Why?
|
Cost of Illness | 1 | 2017 | 1959 | 0.280 |
Why?
|
Hyperlipidemias | 2 | 2024 | 773 | 0.280 |
Why?
|
Mutation, Missense | 6 | 2024 | 2593 | 0.270 |
Why?
|
United States | 20 | 2024 | 73144 | 0.260 |
Why?
|
Heart Diseases | 3 | 2024 | 2819 | 0.260 |
Why?
|
Pregnancy | 10 | 2024 | 30198 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3666 | 0.260 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9508 | 0.260 |
Why?
|
Genetic Loci | 3 | 2021 | 2630 | 0.250 |
Why?
|
Lipase | 2 | 2021 | 321 | 0.250 |
Why?
|
Mice | 24 | 2024 | 82004 | 0.250 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26373 | 0.250 |
Why?
|
Medical Staff, Hospital | 1 | 2009 | 603 | 0.250 |
Why?
|
Disease | 3 | 2024 | 673 | 0.250 |
Why?
|
Hormone Replacement Therapy | 2 | 2022 | 756 | 0.250 |
Why?
|
Prognosis | 7 | 2024 | 30020 | 0.250 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2027 | 0.240 |
Why?
|
Thrombosis | 3 | 2024 | 2955 | 0.230 |
Why?
|
Practice Guidelines as Topic | 3 | 2022 | 7453 | 0.230 |
Why?
|
Calcinosis | 2 | 2023 | 1482 | 0.230 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2192 | 0.230 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14783 | 0.220 |
Why?
|
Apoprotein(a) | 1 | 2023 | 17 | 0.220 |
Why?
|
Influenza Vaccines | 1 | 2011 | 780 | 0.220 |
Why?
|
Genome | 2 | 2022 | 1747 | 0.220 |
Why?
|
Diet | 1 | 2021 | 8097 | 0.210 |
Why?
|
Colchicine | 1 | 2024 | 257 | 0.210 |
Why?
|
Leisure Activities | 1 | 2025 | 310 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3107 | 0.210 |
Why?
|
Apolipoproteins A | 1 | 2023 | 96 | 0.210 |
Why?
|
Cold-Shock Response | 1 | 2022 | 16 | 0.210 |
Why?
|
Alleles | 6 | 2024 | 6892 | 0.210 |
Why?
|
Case-Control Studies | 16 | 2022 | 22292 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2021 | 4774 | 0.210 |
Why?
|
Heterozygote | 6 | 2021 | 2792 | 0.210 |
Why?
|
Radon | 1 | 2024 | 90 | 0.200 |
Why?
|
Blood Proteins | 2 | 2024 | 1186 | 0.200 |
Why?
|
Cholesterol | 4 | 2024 | 2912 | 0.190 |
Why?
|
Sex Factors | 4 | 2024 | 10656 | 0.190 |
Why?
|
Young Adult | 12 | 2024 | 60048 | 0.190 |
Why?
|
Mississippi | 1 | 2021 | 94 | 0.190 |
Why?
|
Leukocytes | 3 | 2024 | 2030 | 0.190 |
Why?
|
Self Report | 2 | 2023 | 3766 | 0.180 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39405 | 0.180 |
Why?
|
alpha Karyopherins | 1 | 2020 | 42 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1812 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 940 | 0.180 |
Why?
|
Albumins | 1 | 2023 | 577 | 0.180 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2004 | 567 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 560 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2023 | 189 | 0.180 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 131 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 572 | 0.180 |
Why?
|
Telomere | 2 | 2023 | 943 | 0.180 |
Why?
|
Lipolysis | 1 | 2021 | 211 | 0.170 |
Why?
|
Micronutrients | 1 | 2023 | 390 | 0.170 |
Why?
|
North America | 1 | 2024 | 1290 | 0.170 |
Why?
|
Lipoprotein Lipase | 2 | 2018 | 133 | 0.170 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9261 | 0.170 |
Why?
|
Multigene Family | 1 | 2023 | 1082 | 0.170 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59683 | 0.170 |
Why?
|
Digestive System Diseases | 1 | 2021 | 152 | 0.170 |
Why?
|
Influenza, Human | 1 | 2011 | 1539 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7955 | 0.160 |
Why?
|
Dicarboxylic Acids | 1 | 2019 | 75 | 0.160 |
Why?
|
Body Mass Index | 6 | 2024 | 13050 | 0.160 |
Why?
|
Time Factors | 6 | 2024 | 40267 | 0.160 |
Why?
|
Periodontitis | 1 | 2024 | 577 | 0.160 |
Why?
|
Smoking | 4 | 2022 | 9109 | 0.160 |
Why?
|
Birth Weight | 2 | 2024 | 2114 | 0.160 |
Why?
|
Waist-Hip Ratio | 2 | 2017 | 520 | 0.160 |
Why?
|
Blood Glucose | 5 | 2021 | 6430 | 0.160 |
Why?
|
Obesity | 6 | 2024 | 13082 | 0.160 |
Why?
|
Insulin Resistance | 3 | 2024 | 3981 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2046 | 0.150 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 279 | 0.150 |
Why?
|
Platelet Aggregation | 1 | 2021 | 769 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 812 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2021 | 1748 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 255 | 0.150 |
Why?
|
Life Change Events | 1 | 2023 | 962 | 0.150 |
Why?
|
Africa | 1 | 2020 | 726 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1736 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 134 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1617 | 0.150 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 2003 | 0.140 |
Why?
|
Eye Proteins | 1 | 2021 | 628 | 0.140 |
Why?
|
Ovariectomy | 1 | 2019 | 615 | 0.140 |
Why?
|
Benchmarking | 1 | 2024 | 1058 | 0.140 |
Why?
|
Aspirin | 3 | 2024 | 3136 | 0.140 |
Why?
|
Signal Transduction | 6 | 2024 | 23629 | 0.140 |
Why?
|
Hospital Records | 1 | 2017 | 93 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1087 | 0.140 |
Why?
|
Risk | 8 | 2021 | 9635 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 706 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 86 | 0.140 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 100 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 520 | 0.140 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 174 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2023 | 984 | 0.130 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1026 | 0.130 |
Why?
|
Apolipoprotein E2 | 1 | 2016 | 134 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 843 | 0.130 |
Why?
|
Incidental Findings | 1 | 2021 | 697 | 0.130 |
Why?
|
Mice, Knockout | 9 | 2024 | 14481 | 0.130 |
Why?
|
Proteins | 2 | 2023 | 6006 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1031 | 0.130 |
Why?
|
Gene Silencing | 3 | 2020 | 1501 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1207 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 288 | 0.120 |
Why?
|
Epigenomics | 1 | 2021 | 959 | 0.120 |
Why?
|
Gout | 1 | 2022 | 621 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2268 | 0.120 |
Why?
|
Heart Defects, Congenital | 2 | 2022 | 4713 | 0.120 |
Why?
|
DNA | 4 | 2023 | 7211 | 0.120 |
Why?
|
Consanguinity | 1 | 2017 | 460 | 0.120 |
Why?
|
Gestational Age | 1 | 2024 | 3615 | 0.120 |
Why?
|
Peptide Hormones | 1 | 2016 | 132 | 0.120 |
Why?
|
Gene Expression | 3 | 2023 | 7595 | 0.120 |
Why?
|
Prevalence | 5 | 2024 | 15868 | 0.120 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2201 | 0.120 |
Why?
|
Blood Platelets | 2 | 2024 | 2476 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1215 | 0.120 |
Why?
|
Adiposity | 1 | 2024 | 1895 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1322 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2022 | 1016 | 0.120 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 614 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11914 | 0.110 |
Why?
|
Eligibility Determination | 1 | 2017 | 421 | 0.110 |
Why?
|
Genes, Dominant | 1 | 2016 | 856 | 0.110 |
Why?
|
Heart Arrest | 1 | 2024 | 1516 | 0.110 |
Why?
|
Genetic Testing | 3 | 2024 | 3587 | 0.110 |
Why?
|
Adolescent | 6 | 2023 | 89182 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 375 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1883 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2019 | 2931 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1065 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1824 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1285 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1092 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1335 | 0.100 |
Why?
|
Biological Transport | 2 | 2010 | 2086 | 0.100 |
Why?
|
Registries | 4 | 2022 | 8378 | 0.100 |
Why?
|
Exercise | 3 | 2024 | 5947 | 0.100 |
Why?
|
Homozygote | 1 | 2017 | 1779 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2957 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8501 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1606 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8730 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1817 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4120 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3794 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2911 | 0.090 |
Why?
|
Sphingosine | 1 | 2013 | 308 | 0.090 |
Why?
|
Stem Cells | 1 | 2024 | 3537 | 0.090 |
Why?
|
Lysophospholipids | 1 | 2013 | 338 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1252 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15939 | 0.090 |
Why?
|
Acetyl-CoA C-Acetyltransferase | 1 | 2010 | 8 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1595 | 0.090 |
Why?
|
Neoplasms | 5 | 2024 | 22389 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6238 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2604 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2889 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2144 | 0.090 |
Why?
|
Base Sequence | 2 | 2018 | 12421 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2103 | 0.090 |
Why?
|
Health Care Costs | 1 | 2023 | 3267 | 0.090 |
Why?
|
Age Factors | 3 | 2024 | 18472 | 0.090 |
Why?
|
Databases, Factual | 3 | 2021 | 8072 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2491 | 0.090 |
Why?
|
Survival Rate | 2 | 2021 | 12870 | 0.080 |
Why?
|
Premature Birth | 1 | 2022 | 1814 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 4427 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2673 | 0.080 |
Why?
|
Niacin | 1 | 2010 | 117 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.080 |
Why?
|
Internship and Residency | 1 | 2009 | 5948 | 0.080 |
Why?
|
Osteoclasts | 2 | 2024 | 711 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3785 | 0.080 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 525 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2017 | 2143 | 0.080 |
Why?
|
Patient Discharge | 1 | 2021 | 3474 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3276 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.080 |
Why?
|
Estonia | 2 | 2018 | 56 | 0.070 |
Why?
|
Coronary Restenosis | 1 | 2010 | 396 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 299 | 0.070 |
Why?
|
Glycemic Index | 1 | 2010 | 400 | 0.070 |
Why?
|
Audiovisual Aids | 1 | 2008 | 99 | 0.070 |
Why?
|
Postprandial Period | 2 | 2021 | 320 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2010 | 461 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3242 | 0.070 |
Why?
|
Anatomy | 1 | 2008 | 126 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10117 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3312 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5511 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5192 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3942 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20766 | 0.060 |
Why?
|
Inpatients | 1 | 2017 | 2569 | 0.060 |
Why?
|
Sample Size | 2 | 2021 | 848 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5711 | 0.060 |
Why?
|
Hospitalists | 1 | 2009 | 298 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4250 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2010 | 806 | 0.060 |
Why?
|
American Heart Association | 2 | 2022 | 1051 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9380 | 0.060 |
Why?
|
Demography | 2 | 2021 | 1642 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 2226 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3826 | 0.060 |
Why?
|
Protein Conformation | 3 | 2014 | 3957 | 0.060 |
Why?
|
Age of Onset | 2 | 2024 | 3345 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3627 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
Ribonucleases | 1 | 2024 | 265 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2025 | 81768 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1197 | 0.060 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2023 | 81 | 0.050 |
Why?
|
Myocytes, Cardiac | 2 | 2024 | 1683 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 163 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2024 | 236 | 0.050 |
Why?
|
Physics | 1 | 2023 | 92 | 0.050 |
Why?
|
Video Recording | 1 | 2008 | 974 | 0.050 |
Why?
|
Depression | 1 | 2023 | 8241 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Pedigree | 2 | 2023 | 4545 | 0.050 |
Why?
|
F-Box Proteins | 1 | 2024 | 201 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2024 | 515 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.050 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 42 | 0.050 |
Why?
|
Child | 4 | 2023 | 80894 | 0.050 |
Why?
|
Bradycardia | 1 | 2024 | 305 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Transcription Factors | 2 | 2023 | 12166 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2024 | 26410 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8747 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22355 | 0.050 |
Why?
|
Arabs | 1 | 2023 | 189 | 0.050 |
Why?
|
Peptides | 2 | 2004 | 4352 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2002 | 295 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 9 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2004 | 1216 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4622 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11220 | 0.040 |
Why?
|
Population Groups | 1 | 2021 | 208 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13696 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 402 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Phytosterols | 1 | 2020 | 55 | 0.040 |
Why?
|
Platelet Activation | 1 | 2024 | 644 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Alendronate | 1 | 2021 | 174 | 0.040 |
Why?
|
Bone Resorption | 1 | 2024 | 727 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2024 | 634 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1418 | 0.040 |
Why?
|
Membrane Transport Proteins | 2 | 2016 | 1034 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 346 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 267 | 0.040 |
Why?
|
Magnesium | 1 | 2023 | 816 | 0.040 |
Why?
|
Critical Pathways | 1 | 2023 | 476 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2020 | 123 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 643 | 0.040 |
Why?
|
Cell Lineage | 2 | 2020 | 2574 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 486 | 0.040 |
Why?
|
Policy | 1 | 2023 | 514 | 0.040 |
Why?
|
Italy | 1 | 2021 | 854 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 842 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 787 | 0.040 |
Why?
|
Norway | 1 | 2020 | 501 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1082 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 680 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2022 | 309 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 168 | 0.040 |
Why?
|
Stents | 1 | 2010 | 3201 | 0.040 |
Why?
|
Protein Transport | 1 | 2004 | 1958 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 922 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 833 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13576 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 628 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 489 | 0.040 |
Why?
|
Program Evaluation | 2 | 2021 | 2505 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7063 | 0.040 |
Why?
|
Face | 1 | 2024 | 1031 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7885 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2024 | 12092 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3439 | 0.040 |
Why?
|
Liposomes | 1 | 2021 | 792 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 19019 | 0.040 |
Why?
|
Leukocyte Rolling | 1 | 2017 | 69 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1226 | 0.040 |
Why?
|
Gene Targeting | 1 | 2020 | 841 | 0.040 |
Why?
|
Osteogenesis | 1 | 2024 | 1291 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1255 | 0.030 |
Why?
|
Parity | 1 | 2020 | 938 | 0.030 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.030 |
Why?
|
Postpartum Period | 1 | 2024 | 1197 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1229 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 1998 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1126 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 303 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1642 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2017 | 201 | 0.030 |
Why?
|
Interleukins | 1 | 2021 | 795 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 1020 | 0.030 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 272 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 954 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2727 | 0.030 |
Why?
|
Pakistan | 1 | 2017 | 298 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2017 | 212 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1526 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21163 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1727 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8902 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 204 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 505 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1966 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1405 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2016 | 240 | 0.030 |
Why?
|
Liver | 2 | 2021 | 7570 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1339 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 220 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6277 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1945 | 0.030 |
Why?
|
Metabolome | 1 | 2022 | 1008 | 0.030 |
Why?
|
Prediabetic State | 1 | 2021 | 548 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2204 | 0.030 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2017 | 348 | 0.030 |
Why?
|
Income | 1 | 2023 | 1877 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2008 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2724 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 351 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1673 | 0.030 |
Why?
|
Basophils | 1 | 2016 | 407 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 746 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2117 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5878 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2425 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2050 | 0.030 |
Why?
|
Immunoblotting | 1 | 2017 | 1647 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 390 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 704 | 0.030 |
Why?
|
Potassium Channels | 1 | 2016 | 538 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1743 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4847 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2122 | 0.030 |
Why?
|
Education | 1 | 2016 | 535 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1970 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 997 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 572 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7242 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1137 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3622 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2016 | 1605 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1183 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.030 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2013 | 123 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2257 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4137 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2015 | 792 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10776 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1421 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2021 | 11659 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2023 | 5800 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2017 | 1337 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2006 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2022 | 2240 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5044 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7145 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2016 | 1165 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14154 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2022 | 2961 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 630 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1610 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2967 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.020 |
Why?
|
Anilides | 1 | 2013 | 414 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1368 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7861 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2661 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3541 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3230 | 0.020 |
Why?
|
Drug Costs | 1 | 2017 | 1196 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2003 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4449 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6541 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2392 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3412 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2022 | 7599 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65365 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5802 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4419 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3064 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4286 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12801 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6670 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3349 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4748 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10377 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3776 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4630 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2693 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1371 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10588 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18358 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9563 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5538 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3960 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2461 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3108 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4940 | 0.010 |
Why?
|
Lipoxygenase | 1 | 2002 | 72 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10844 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13323 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6608 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8326 | 0.010 |
Why?
|
Program Development | 1 | 2008 | 1298 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2002 | 276 | 0.010 |
Why?
|
Educational Measurement | 1 | 2008 | 1256 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5214 | 0.010 |
Why?
|
Glutathione | 1 | 2002 | 585 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36512 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6881 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42654 | 0.010 |
Why?
|
Cysteine | 1 | 2002 | 895 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10464 | 0.010 |
Why?
|
Curriculum | 1 | 2008 | 3775 | 0.010 |
Why?
|
Cell Line | 1 | 2002 | 15593 | 0.000 |
Why?
|
Macrophages | 1 | 2002 | 5796 | 0.000 |
Why?
|